Intravenous Immunoglobulin (IVIG) Therapy for COVID-19 Omicron (B.1.1.529) Variant with Acute Respiratory Distress Syndrome
Background: COVID-19 become the pandemic and infect more than million people. The World health organization and other clinical institutions have not yet established a definitive therapy to treat this disease due to a rapid virus mutation and anomaly. Case: A 78-year-old man who had previously con...
Main Authors: | Dewi Arum Sawitri, Arie Zainul Fatoni |
---|---|
Format: | Article |
Language: | English |
Published: |
Anesthesiology and Intensive Therapy Specialist Program, Brawijaya University
2023-01-01
|
Series: | Journal of Anaesthesia and Pain |
Subjects: | |
Online Access: | https://jap.ub.ac.id/index.php/jap/article/view/144 |
Similar Items
-
The effects of hair regrowth with intravenous immunoglobulin (IVIG) therapy. Two case reports
by: Joseph A. Cahill, et al.
Published: (2017-07-01) -
Timing of infections in patients with primary immunodeficiencies treated with intravenous immunoglobulin (IVIg)
by: Parwinder K. Gill, et al.
Published: (2018-08-01) -
The therapeutic window of intravenous immunoglobulin (IVIG) and its correlation with clinical outcomes in Kawasaki disease: a systematic review and meta-analysis
by: Zheng Li, et al.
Published: (2023-04-01) -
Intravenous immunoglobulins (IVIG) in severe/critical COVID-19 adult patients
by: Dorota Kwapisz, et al.
Published: (2023-07-01) -
Injection of intravenous immunoglobulin (IVIg) for the treatment of Coronavirus induced cytokine storm
by: Farahnoosh Farnood, et al.
Published: (2022-12-01)